Cannabis Producer - Benchmark Botanics - BBT.C Investment Highlights - Health Canada Licensed Producer and Distributor under the Cannabis Act and its Regulations
- Medical, Pharmaceutical & Wellness Markets
- Sales & Revenues, from Peachland Cannabis Complex
- Peachland Expansion to 62,500 sq. ft
- Pitt Meadows Greenhouse 174,240 sq. ft
- Established EU Partnerships for Export
- Asia-Pacific Markets - JV Zhejiang Yatai Pharmaceutical
- Over 60 Genetic Strains
- Closed $11M financing
About Benchmark Botanics Inc. Benchmark Botanics is a diversified multi licensed cannabis producer focused on a three-way vertical business model targeting the medical, pharmaceutical and recreational markets in Canada and the European Union. The company's business plan also includes a strategy to be the first Canadian licensed producer to be selling medical cannabis and hemp throughout Asia through its JV partnership with Zhejiang Yatai Pharmaceutical
https://en.yataipharma.com/ which is part of the Yatai Group
https://en.yatai.com/ a China based top 500 enterprises.
Zhejiang Yatai Pharmaceutical founded in 1989 researches, produces, sells, and exports pharmaceutical products, tablets, capsules, patches, powder injections in China and internationally.
Revenue $188.29 M USD 2018
Net Income: $30.1M USD 2018
Market Cap $ 8.525 B USD
803 employees
50 offices in 24 provinces in China
GMP standards / modern pharmaceutical production techniques
2002 ISO 9001 quality certification – ISO 14001 environmental protection
https://benchmarkbotanics.com/